BioSpace News Archive

Soundbite Medical Solutions Inc. (SBMS), a medical device company dedicated to developing solutions for the interventional treatment of calcific peripheral and coronary arterial diseases, today announced the use of its novel Active Wire 0.014” platform at a prominent site in Germany with the successful treatment of patients suffering from heavily calcified lower limb chronic total occlusions (CTO).

Derm-Biome Pharmaceuticals, Inc, a private Vancouver based biopharmaceutical company focused on skin health and healthy ageing, is pleased to announce that on June 14, 2021 it filed US provisional patent application entitled “COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATORY SKIN CONDITIONS” (U.S. Provisional Application No. 63/210177).

Data from the SURPASS global clinical development program for Eli Lilly and Company’s tirzepatide, a novel investigational once-weekly medication for the treatment of type 2 diabetes, demonstrates statistically significant A1C and weight reductions versus several comparators.

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2021 on Tuesday, July 27, 2021 at 8:00 a.m. EDT .

Prilenia Therapeutics B.V., a clinical stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders, received a positive opinion on European Orphan Drug Designation for pridopidine in Amyotrophic lateral sclerosis (ALS).

Kane Biotech Inc. will host investor meetings at the 10th AnnualWhistler 2021 Capital Conference hosted by Capital Event Management the weekend of July 9-11, 2021 at The Fairmont Chateau, Whistler.

Cortica, Inc., a leader in technology-enabled clinical services for autism and other neurodevelopmental conditions, announced a $60 million financing to further its mission to transform autism care.

Inova Diagnostics, a worldwide leader in IVD systems and reagents for autoimmune disease in the clinical laboratory, is pleased to announce FDA 510(k) clearance of its Aptiva® System and Aptiva® Celiac Disease IgA assay.

MedPro Systems and its Compliance Advisory Services team today announced a partnership with PharmaCertify, the compliance training division of NXLevel Solutions, to help Life Sciences organizations implement more effective and cohesive compliance programs.

Venatorx Pharmaceuticals today announced that Mary Beth Dorr, Ph.D. has joined the Company as Vice President, Clinical Science.